Litigation Details for Eli Lilly and Company v. Lupin Limited (D. Del. 2018)
✉ Email this page to a colleague
Eli Lilly and Company v. Lupin Limited (D. Del. 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-01-03 |
| Court | District Court, D. Delaware | Date Terminated | 2018-05-24 |
| Cause | 35:271 Patent Infringement | Assigned To | Vacant Judgeship |
| Jury Demand | None | Referred To | Mary Pat Thynge |
| Patents | 6,943,166 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Eli Lilly and Company v. Lupin Limited
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for Eli Lilly and Company v. Lupin Limited (D. Del. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-01-03 | 1 | e)(2) for infringement of U.S. Patent No. 6,943,166 (“the ’166 patent”). … 1. This is an action for patent infringement arising under the patent laws of the United States, … PATENT-IN-SUIT 30. On September 13, 2005, the U.S. Patent and Trademark Office…copy of the ’166 patent is attached hereto as Exhibit A. The claims of the ’166 patent are valid and enforceable…and 20 mg dosage strengths. The ’166 patent is one of the patents listed in the FDA publication entitled | External link to document | |
| 2018-01-03 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,943,166. (nmfn) (Entered: 01… 2018 24 May 2018 1:18-cv-00055 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
